HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kathryn E Meier Selected Research

Kathryn E Meier Research Topics

Disease

9Prostatic Neoplasms (Prostate Cancer)
03/2024 - 09/2002
8Neoplasms (Cancer)
03/2024 - 01/2010
5Neoplasm Metastasis (Metastasis)
02/2024 - 09/2008
5Lymphoma (Lymphomas)
08/2011 - 01/2007
3Carcinoma (Carcinomatosis)
03/2024 - 09/2002
2Ovarian Neoplasms (Ovarian Cancer)
07/2017 - 01/2010
1Pheochromocytoma
03/2024
1Colonic Neoplasms (Colon Cancer)
02/2024
1Carcinogenesis
01/2018
1Breast Neoplasms (Breast Cancer)
01/2016
1Inflammation (Inflammations)
11/2006
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2006
1Atherosclerosis
08/2002

Drug/Important Bio-Agent (IBA)

9lysophosphatidic acidIBA
03/2024 - 09/2002
5Proteins (Proteins, Gene)FDA Link
03/2024 - 08/2011
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2024 - 11/2006
4Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2019 - 02/2015
4Nonesterified Fatty Acids (NEFA)IBA
07/2017 - 01/2016
4phospholipase D2IBA
11/2016 - 09/2008
4Epidermal Growth Factor (EGF)IBA
10/2016 - 01/2010
3LipidsIBA
09/2023 - 09/2002
3phorbolIBA
08/2011 - 01/2007
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
03/2024 - 10/2009
2ErbB Receptors (EGF Receptor)IBA
10/2016 - 01/2016
2Lysophosphatidic Acid ReceptorsIBA
10/2016 - 01/2016
2CarcinogensIBA
05/2009 - 01/2007
2Phorbol EstersIBA
05/2009 - 01/2007
2Phosphotransferases (Kinase)IBA
11/2006 - 05/2006
1EnzymesIBA
03/2024
1Phospholipids (Phosphatides)FDA LinkGeneric
03/2024
1MitogensIBA
03/2024
1Cysteine-Rich Protein 61IBA
09/2023
1Biomarkers (Surrogate Marker)IBA
01/2018
1Messenger RNA (mRNA)IBA
07/2017
1Fatty Acids (Saturated Fatty Acids)IBA
01/2017
1beta-Arrestin 2IBA
10/2016
1AcidsIBA
01/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2015
1CalpainIBA
11/2012
1Focal Adhesion Protein-Tyrosine KinasesIBA
11/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2006
1Imatinib Mesylate (Gleevec)FDA Link
05/2006
1Dasatinib (BMS 354825)FDA Link
05/2006
1Triglycerides (Triacylglycerol)IBA
08/2002
1Lipoproteins (Lipoprotein)IBA
08/2002

Therapy/Procedure

2Therapeutics
07/2017 - 01/2017